Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuharu Kai

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Cell & Developmental Biology|December 21, 2017
Secretory microRNAs as biomarkers of cancerKazuharu Kai, Rachel L Dittmar, Subrata Sen
Breast Cancer (Tokyo, Japan)|October 7, 2009
Breast cancer stem cellsKazuharu Kai, Yoshimi Arima, Toshio Kamiya, et al.
Cancer Hallmarks|October 14, 2014
A Brief Review of the Biophysical Hallmarks of Metastatic Cancer CellsWeijia Zhang, Kazuharu Kai, Naoto T Ueno, et al.
International Journal of Clinical Oncology|December 21, 2006
p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort studyKazuharu Kai, Reiki Nishimura, Nobuyuki Arima, et al.
Frontiers in Oncology|December 10, 2016
Functional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerKaori Sasai, Warapen Treekitkarnmongkol, Kazuharu Kai, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2008
Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort studyKazuharu Kai, Nobuyuki Arima, Haruhiko Miyayama, et al.
BMC Cancer|September 18, 2008
Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancerKazuharu Kai, Zhenhuan Zhang, Hiroko Yamashita, et al.
Breast Cancer Research and Treatment|September 7, 2007
Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancerYutaka Yamamoto, Mutsuko Ibusuki, Yasuhiro Okumura, et al.
Oncology Letters|August 7, 2012
Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapyMitsuhiro Hayashi, Kazuharu Kai, Yasuhiro Okumura, et al.
Cancer Science|December 24, 2009
CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesisTakatsugu Ishimoto, Hiroko Oshima, Masanobu Oshima, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Cell & Developmental Biology|December 21, 2017
Secretory microRNAs as biomarkers of cancerKazuharu Kai, Rachel L Dittmar, Subrata Sen
Breast Cancer (Tokyo, Japan)|October 7, 2009
Breast cancer stem cellsKazuharu Kai, Yoshimi Arima, Toshio Kamiya, et al.
Cancer Hallmarks|October 14, 2014
A Brief Review of the Biophysical Hallmarks of Metastatic Cancer CellsWeijia Zhang, Kazuharu Kai, Naoto T Ueno, et al.
International Journal of Clinical Oncology|December 21, 2006
p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort studyKazuharu Kai, Reiki Nishimura, Nobuyuki Arima, et al.
Frontiers in Oncology|December 10, 2016
Functional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerKaori Sasai, Warapen Treekitkarnmongkol, Kazuharu Kai, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2008
Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort studyKazuharu Kai, Nobuyuki Arima, Haruhiko Miyayama, et al.
BMC Cancer|September 18, 2008
Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancerKazuharu Kai, Zhenhuan Zhang, Hiroko Yamashita, et al.
Breast Cancer Research and Treatment|September 7, 2007
Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancerYutaka Yamamoto, Mutsuko Ibusuki, Yasuhiro Okumura, et al.
Oncology Letters|August 7, 2012
Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapyMitsuhiro Hayashi, Kazuharu Kai, Yasuhiro Okumura, et al.
Cancer Science|December 24, 2009
CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesisTakatsugu Ishimoto, Hiroko Oshima, Masanobu Oshima, et al.
Pageof 3